Skip to content
OrtaakarsuMedicine information

Source-based medicine information

Telfast 180 mg

Telfast 180 mg: free medicine identity, available formulation details and reference links. Generic / active ingredient: Feksofenadin Hidroklorür.

Free preview

Essential record information

Public access

Review the free medicine identity and available source information for Telfast 180 mg. Detailed uses, safety and interaction information is in this page’s access section.

Telfast 180 mg

Active ingredient / generic name
Feksofenadin Hidroklorür
ATC code
R06AX26
Record type
Medicine information record
Record sources

Source checked:

A source check is not an independent clinical review.

Access to this record

Free preview
Medicine identities, available source links and, where available, selected low-level related interaction records.
Paid details
Available detailed medicine uses, safety information and interaction context can be read with single-page access or an eligible membership page allowance.

A single-page purchase unlocks this resource only. Membership provides the page allowance shown in your plan; it does not unlock every related record automatically.

  • This page only: 6.00 USD One-time payment
  • Monthly membership: 40.00 USD / month · starting price

A free account with a verified email address is required before checkout. Monthly membership renews automatically with no trial period. Taxes and the final total appear in checkout.

Examples selected from real records

Selected free interaction examples

Free

Selected low-level interaction records involving this medicine and other medicines are shown. This is not the complete interaction list.

Published related records: 9. The selection below does not represent the complete list.

Examples selected from real records

Published records

The identity and source of these published related records are shown below. Clinical details are displayed according to your access to each record.

Important information and detailed context

Unlock medicine and interaction details

The basic information is available above. Details such as explanations of moderate or severe interaction records, mechanisms and clinical context are available through paid access to the relevant record or your membership allowance.

The related record group also includes interactions classified as moderate or severe. Each record’s access right applies to its own details.

  • Uses and medicine information
  • Safety and special circumstances
  • Side effects and interaction details

This page only

6.00 USDOne-time payment

Permanent access to this record and its available language versions. No subscription required.

Buy access to this page

Monthly membership

40.00 USD/ month · starting price

30 different records per billing period. Reading a record again in the same period does not use another page allowance.

Explore memberships

Monthly memberships renew automatically; there is no trial period. Taxes and the final total appear in checkout.

A verified account is required. Turkish and English versions of the same resource share one access right.

This information is not personal treatment advice. Discuss treatment decisions with your doctor or pharmacist.